On the other hand, the p value of 0.056 raises the possibility that with more trials, there might be significant differences among the active treatments with respect to values for percentages of patients with diarrhoea.
← all excerpts
Persistent constipation and abdominal adverse events with newer treatments for constipation.
1
—
—